Mitochondrial Genetic Polymorphisms and Pancreatic Cancer Risk
Open Access
- 1 July 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 16 (7) , 1455-1459
Abstract
The role of genes that influence the risk of developing pancreatic cancer (PC) has not been well studied. The mitochondrion, conventionally thought to be an organelle specific to energy metabolism, is in fact multifunctional and has been implicated in many diseases, including cancer. To evaluate whether single nucleotide polymorphisms in mitochondrial DNA (mtSNP) are associated with increased risk of PC, we screened Caucasian cases diagnosed or seen at the Mayo Clinic with primary pancreatic adenocarcinoma (n = 955), and healthy clinic-based Caucasian controls (n = 1,102). A total of 24 mtSNPs, including 10 of the most common tagSNPs, 7 non-tagSNPs in the coding region, and 7 common SNPs in the regulatory region were genotyped. For analysis, these samples were grouped into two phases, the “testing” set (474 cases and 615 controls), and the “validation” set (481 cases and 487 controls). In the testing set, one mtSNP (SNP11719) suggested an association in single SNP analysis, with an odds ratio of 1.34 (95% confidence intervals, 1.05-1.72; P = 0.020), but did not remain statistically significant after correction for multiple testing. In the validation set, none of the 24 variants indicated any association with PC. For haplogroup analysis, 10 core SNPs that form common haplogroups in Caucasians (1719, 4580, 7028, 8251, 9055, 10398, 12308, 13368, 13708, and 16391) were evaluated. No significant associations with PC were identified either by analyzing the two sets separately or combined (combined global P = 0.17). Overall, these results do not support a significant involvement of mitochondrial DNA variation in the risk of developing PC. Investigation of other mitochondrial genetic variations (i.e., nuclear-encoded mitochondrial proteins) would be necessary to elucidate any role of mitochondrial DNA variation in PC. (Cancer Epidemiol Biomarkers Prev 2007;16(7):1455–9)Keywords
This publication has 24 references indexed in Scilit:
- HIF and fumarate hydratase in renal cancerBritish Journal of Cancer, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Mitochondrial DNA D-Loop in Pancreatic CancerAmerican Journal of Clinical Pathology, 2006
- Genetic Testing in Pheochromocytoma‐ and Paraganglioma‐Associated SyndromesAnnals of the New York Academy of Sciences, 2006
- Comprehensive Association Testing of Common Mitochondrial DNA Variation in Metabolic DiseaseThe American Journal of Human Genetics, 2006
- Mitochondrial DNA mutations in human diseaseNature Reviews Genetics, 2005
- Mitochondrial Dysfunction Is a Common Phenotype in Aging and CancerAnnals of the New York Academy of Sciences, 2004
- Mitochondrial DNA Somatic Mutations (Point Mutations and Large Deletions) and Mitochondrial DNA Variants in Human Thyroid PathologyThe American Journal of Pathology, 2002
- Score Tests for Association between Traits and Haplotypes when Linkage Phase Is AmbiguousThe American Journal of Human Genetics, 2002
- Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumoursOncogene, 2000